A retrospective, multicentre study evaluating efficacy of Ruxolitinib in chronic graft-versus-host disease treatment
Latest Information Update: 04 Jan 2021
At a glance
- Drugs Ruxolitinib (Primary) ; Prednisone
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 04 Jan 2021 New trial record
- 08 Dec 2020 Results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology